Tyrosine-phosphorylated Vav1 as a point of integration for T-cell receptor- and CD28-mediated activation of JNK, p38, and interleukin-2 transcription

被引:76
作者
Hehner, SP [1 ]
Hofmann, TG [1 ]
Dienz, O [1 ]
Dröge, W [1 ]
Schmitz, ML [1 ]
机构
[1] Deutsch Krebsforschungszentrum, Dept Immunochem, D-69120 Heidelberg, Germany
关键词
D O I
10.1074/jbc.275.24.18160
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study Re identified tyrosine-phosphorylated Vav1 as an early point of integration between the signaling routes triggered by the T-cell receptor and CD28 in human T-cell leukemia cells. Costimulation resulted in a prolonged and sustained phosphorylation and membrane localization of Vav1 in comparison to T-cell receptor activation alone. T-cell stimulation induced the recruitment of Vav1 to an inducible multiprotein T-cell activation signaling complex at the plasma membrane. Vav1 activated the mitogen-activated protein kinases JNK and p38. The Vav1-mediated activation of JNK employed a pathway involving Rac, HPK1, MLK3, and MKK7. The costimulation-induced activation of p38 was inhibited by dominant negative forms of Vav1, Pac, and MKK6. Here we show that Vav1 also induces transcription factors that bind to the CD28RE/AP element contained in the interleukin-2 promoter. A detailed mutational analysis of Vav1 revealed a series of constitutively active and nonfunctional forms of Vav1. Almost all inactive versions were mutated in their Dbl homology domain and behaved as dominant negative mutants that impaired costimulation-induced activation of JNK, p38, and CD28RE/AP-dependent transcription. In contrast to NF-AT-dependent transcription, Vav1-mediated transcriptional induction of the CD28RE/AP element in the interleukin-a promoter could only partially be inhibited by cyclosporin A, suggesting a dual role of Vav1 for controlling Ca2+-dependent and -independent events.
引用
收藏
页码:18160 / 18171
页数:12
相关论文
共 62 条
[1]   The Src homology 2 domain of Vav is required for its compartmentation to the plasma membrane and activation of C-jun NH2-terminal kinase 1 [J].
Arudchandran, R ;
Brown, MJ ;
Peirce, MJ ;
Song, JS ;
Zhang, JA ;
Siraganian, RP ;
Blank, U ;
Rivera, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (01) :47-59
[2]   INOSITOL TRISPHOSPHATE AND CALCIUM SIGNALING [J].
BERRIDGE, MJ .
NATURE, 1993, 361 (6410) :315-325
[3]   The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor [J].
Beyaert, R ;
Cuenda, A ;
VandenBerghe, W ;
Plaisance, S ;
Lee, JC ;
Haegeman, G ;
Cohen, P ;
Fiers, W .
EMBO JOURNAL, 1996, 15 (08) :1914-1923
[4]   A THEORY OF SELF-NONSELF DISCRIMINATION [J].
BRETSCHER, P ;
COHN, M .
SCIENCE, 1970, 169 (3950) :1042-+
[5]   Lymphocyte signalling: A coordinating role for Vav? [J].
Cantrell, D .
CURRENT BIOLOGY, 1998, 8 (15) :R535-R538
[6]  
CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20
[7]  
COPPOLA J, 1991, CELL GROWTH DIFFER, V2, P95
[8]   THE SMALL GTP-BINDING PROTEINS RAC1 AND CDC42 REGULATE THE ACTIVITY OF THE JNK/SAPK SIGNALING PATHWAY [J].
COSO, OA ;
CHIARIELLO, M ;
YU, JC ;
TERAMOTO, H ;
CRESPO, P ;
XU, NG ;
MIKI, T ;
GUTKIND, JS .
CELL, 1995, 81 (07) :1137-1146
[9]   The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-κB pathways [J].
Costello, PS ;
Walters, AE ;
Mee, PJ ;
Turner, M ;
Reynolds, LF ;
Prisco, A ;
Sarner, N ;
Zamoyska, R ;
Tybulewicz, VLJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :3035-3040
[10]  
Crespo P, 1996, ONCOGENE, V13, P455